Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants | Zendy

JeanChristophe Rozé | Zendy; Gilles Cambonie | Zendy; Laetitia MarchandMartin | Zendy; V. Gournay | Zendy; Xavier Durrmeyer | Zendy; Mélanie Durox | Zendy; Laurent Storme | Zendy; Raphaël Porcher | Zendy; PierreYves Ancel | Zendy

Open Access

Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants

Author(s) -

JeanChristophe Rozé,

Gilles Cambonie,

Laetitia MarchandMartin,

V. Gournay,

Xavier Durrmeyer,

Mélanie Durox,

Laurent Storme,

Raphaël Porcher,

PierreYves Ancel

Publication year - 2015

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2015.6734

Subject(s) - medicine , necrotizing enterocolitis , ductus arteriosus , bronchopulmonary dysplasia , pediatrics , neonatal intensive care unit , odds ratio , intraventricular hemorrhage , population , propensity score matching , gestational age , gestation , prospective cohort study , pregnancy , environmental health , biology , genetics

There is currently no consensus for the screening and treatment of patent ductus arteriosus (PDA) in extremely preterm infants. Less pharmacological closure and more supportive management have been observed without evidence to support these changes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research